Abstract: Disclosed is system (100) and method (200) for providing energy management in communication network (700). The system (100) comprises a plurality of the solar-enabled Base Stations (BSs) (300-n) connected to a power grid (600) and a core network (800) configured in the communication network (700). The core network (800) comprises a controller (102) configured for enabling energy exchange among the energy-deficient BS from the plurality of BSs (300-n) and energy-sufficient BS from the plurality of BSs (300) through the power grid (600), thus reducing the carbon footprint. The controller (102) is also configured for cooperatively adjusting network coverage area for each of the BS of the plurality of BSs (300-n). The power grid (600) operates in an energy prosumer mode, providing flexibility to the plurality of BSs (300-n) to procure energy from it to avoid energy outage or sell surplus energy back to the grid.

Abstract: The present invention relates to compounds and pharmaceutical composition having antiviral effects. Over 1200 molecules were screened and 55 molecules having statistically significant anti-HIV activity were identified and selected. The compound Methotrexate (MTX-HYD) and its analogues, the combinations thereof and their combination with other anti-retrovirals were selected for repurposing the compounds as anti-HIV drugs. The present invention may further relate to pharmaceutical composition comprising compounds in combination with active drugs having anti-HIV activity.

Abstract: Acaciaside-B (Ac-B) has emerged as a prospective candidate molecule for prevention of HIV infection along with potential for use as/in vaginal contraceptive/formulation. It possesses anti-HIV property at a tolerably low concentration, is non-mutagenic and does not harm the niche of Lactobacilli. Thus Ac-B appears to be a superior ingredient for formulations of a chemical barrier against HIV-1 infection wherein its spermicidal property is superfluous.

Abstract: Acaciaside-B (Ac-B) has emerged as a prospective candidate molecule for prevention of HIV infection along with potential for use as/in vaginal contraceptive/formulation. It possesses anti-HIV property at a tolerably low concentration, is non-mutagenic and does not harm the niche of Lactobacilli. Thus Ac-B appears to be a superior ingredient for formulations of a chemical barrier against HIV-1 infection wherein its spermicidal property is superfluous.